Nanomedicine Emerging Prospects /
This book highlights the emerging paradigm of nanomedicine, intersecting two burgeoning fields of nanotechnology and medicine. Numerous publications have appeared in the literature over the years, especially in cancer nanomedicine. In a boarder sense, nanomedicine aims to apply the knowledge and too...
Guardat en:
| Autor principal: | |
|---|---|
| Autor corporatiu: | |
| Format: | Electrònic eBook |
| Idioma: | anglès |
| Publicat: |
Singapore :
Springer Nature Singapore : Imprint: Springer,
2023.
|
| Edició: | 1st ed. 2023. |
| Col·lecció: | Nanotheranostics,
|
| Matèries: | |
| Accés en línia: | https://doi.org/10.1007/978-981-99-2139-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-981-99-2139-3 | ||
| 003 | DE-He213 | ||
| 005 | 20260906082429.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 230614s2023 si | o |||| 0|eng d | ||
| 020 | |a 9789819921393 |9 978-981-99-2139-3 | ||
| 024 | 7 | |a 10.1007/978-981-99-2139-3 |2 doi | |
| 050 | 4 | |a QH505 | |
| 072 | 7 | |a PHVN |2 bicssc | |
| 072 | 7 | |a SCI009000 |2 bisacsh | |
| 072 | 7 | |a PHVN |2 thema | |
| 082 | 0 | 4 | |a 571.4 |2 23 |
| 100 | 1 | |a Tamil Selvan, Subramanian. |e author. |4 aut |4 http://id.loc.gov/vocabulary/relators/aut | |
| 245 | 1 | 0 | |a Nanomedicine |h [electronic resource] : |b Emerging Prospects / |c by Subramanian Tamil Selvan. |
| 250 | |a 1st ed. 2023. | ||
| 264 | 1 | |a Singapore : |b Springer Nature Singapore : |b Imprint: Springer, |c 2023. | |
| 300 | |a 1 online resource (VI, 73 p. 22 illus.). |b 20 illus. in color. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 341 | 0 | |b Table of contents navigation |2 onix | |
| 341 | 0 | |b Single logical reading order |2 onix | |
| 341 | 0 | |b Short alternative textual descriptions |2 onix | |
| 341 | 0 | |b Use of colour is Not sole means of conveying information |2 onix | |
| 341 | 0 | |b Use of high contrast between text and background colour |2 onix | |
| 341 | 0 | |b Next / Previous structural navigation |2 onix | |
| 341 | 0 | |b All Non-decorative content supports reading without sight |2 onix | |
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Nanotheranostics, |x 2197-6759 | |
| 505 | 0 | |a 1. Introduction to Nanomedicine -- 2. Cancer Nanomedicine -- 3. Nanomedicine for Neurodegenerative Diseases -- 4. Nanomedicine for Orthopedics -- 5. Nanomedicine for Cardiac Diseases.-6.Conclusions and Perspectives. . | |
| 520 | |a This book highlights the emerging paradigm of nanomedicine, intersecting two burgeoning fields of nanotechnology and medicine. Numerous publications have appeared in the literature over the years, especially in cancer nanomedicine. In a boarder sense, nanomedicine aims to apply the knowledge and tools of nanotechnology in a mission to diagnose early and prevent or treat diseases using biocompatible nanoparticles (NPs). Current research in nanomedicine and its prospects depend on creating new breakthroughs at the nexus of nanomaterials and biological systems, making use of non-toxic NPs and nano/biomaterials as smart theranostic systems for a variety of diseases including cancer, neurodegenerative, orthopedic, and cardiac diseases. This book provides a review on recent advancements of nanomedicine in the aforementioned emerging areas of nanomedicine. | ||
| 532 | 8 | |a Accessibility summary: This PDF does Not fully comply with PDF/UA standards but does include limited screen reader support, descriptions for Non-text content (such as images and graphs), bookmarks for easy navigation, and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognise the importance of accessibility and welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us via https://www.springernature.com/gp/info/accessibility | |
| 532 | 8 | |a Inaccessible, or known limited accessibility | |
| 532 | 8 | |a No reading system accessibility options actively disabled | |
| 532 | 8 | |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 588 | |a Print version record. | ||
| 650 | 0 | |a Biophysics. | |
| 650 | 0 | |a Nanochemistry. | |
| 650 | 0 | |a Therapeutics. | |
| 650 | 0 | |a Nanomedicine. | |
| 650 | 0 | |a Medical physics. | |
| 650 | 1 | 4 | |a Bioanalysis and Bioimaging. |
| 650 | 2 | 4 | |a Nanochemistry. |
| 650 | 2 | 4 | |a Therapeutics. |
| 650 | 2 | 4 | |a Nanomedicine and Nanotoxicology. |
| 650 | 2 | 4 | |a Medical Physics. |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9789819921386 |
| 776 | 0 | 8 | |i Printed edition: |z 9789819921409 |
| 830 | 0 | |a Nanotheranostics, |x 2197-6759 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-981-99-2139-3 |
| 912 | |a ZDB-2-PHA | ||
| 912 | |a ZDB-2-SXP | ||
| 950 | |a Physics and Astronomy (SpringerNature-11651) | ||
| 950 | |a Physics and Astronomy (R0) (SpringerNature-43715) | ||